Atlas Trials

A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial

Clinical trial NCT05205837 · TERMINATED

Trial details

NCT number
NCT05205837
Sponsor
Rigshospitalet, Denmark
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
HypogonadismHypogonadism, MaleHypogonadotropic Hypogonadism
Start date
2021-11-24
Primary completion
2023-08-15
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.